Vicarious Surgical Inc. (RBOT) Research

Vicarious Surgical Inc. is dedicated to the development and commercialization of advanced single-incision surgical robotics. Their innovative technology is designed to give surgeons a virtual, immersive presence within the patient's body, facilitating highly precise and minimally invasive operations. The company's primary product, the Vicarious System, is a sophisticated single-incision robot engineered specifically for procedures like ventral hernia repair. Established in 2014, Vicarious Surgical Inc. operates from its corporate headquarters in Waltham, Massachusetts.

Market snapshot

Symbol
RBOT
Price
$0.23
Day change
+6.98%
Market cap
$1.5M
P/E ratio
-0.04x
52-week range
0.17-13.746
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 1 month
Analyst price target
$8.75

Peer companies

  • Boundless Bio, Inc. (BOLD)
  • Hyperion DeFi, Inc. (HYPD)
  • Intensity Therapeutics, Inc. (INTS)
  • Iterum Therapeutics plc (ITRM)
  • Modular Medical, Inc. (MODD)
  • Myomo, Inc. (MYO)
  • Nexalin Technology, Inc. (NXL)
  • P3 Health Partners Inc. (PIII)

Recent insider activity

  • Sachs Adam David — S-Sale (942 shares) on 2026-02-20
  • Khalifa Sammy — S-Sale (754 shares) on 2026-02-20
  • Sachs Adam David — S-Sale (463 shares) on 2025-12-03
  • Khalifa Sammy — S-Sale (239 shares) on 2025-12-03
  • Khalifa Sammy — S-Sale (653 shares) on 2025-11-20

Open Vicarious Surgical Inc. (RBOT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.